Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0001081
UniProt IDP49771
Primary gene name(s)FLT3LG
Synonym gene name(s)unknown
Protein nameFms-related tyrosine kinase 3 ligand
Protein functionStimulates the proliferation of early hematopoietic cells by activating FLT3. Synergizes well with a number of other colony stimulating factors and interleukins.
Subcellular locationIsoform 1: Cell membrane;
Single-pass type I membrane protein.;
SUBCELLULAR LOCATION: Isoform 2: Secreted.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P49771
Gene Ontology
(Biological Process)
Complete annatation
embryonic hemopoiesis [GO:0035162];
homeostasis of number of cells within a tissue [GO:0048873];
lymphocyte differentiation [GO:0030098];
negative regulation of apoptotic process in bone marrow [GO:0071866];
positive regulation of cell cycle [GO:0045787];
positive regulation of cell proliferation [GO:0008284];
positive regulation of cell proliferation in bone marrow [GO:0071864];
positive regulation of myoblast differentiation [GO:0045663];
positive regulation of myoblast fusion [GO:1901741];
positive regulation of natural killer cell differentiation [GO:0032825];
positive regulation of osteoclast proliferation [GO:0090290];
positive regulation of protein phosphorylation [GO:0001934];
positive regulation of transcription from RNA polymerase II promoter [GO:0045944];
regulation of myeloid dendritic cell activation [GO:0030885];
signal transduction [GO:0007165]
Gene Ontology
(Molecular Function)
Complete annatation
receptor binding [GO:0005102]
Gene Ontology
(Cellular Component)
Complete annatation
extracellular region [GO:0005576];
extracellular space [GO:0005615];
integral component of membrane [GO:0016021];
intrinsic component of external side of plasma membrane [GO:0031233];
membrane [GO:0016020]
Protein-protein interaction108611
Phylogenetic treeP49771
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-2.915533906546192.22044604925031e-168.94827883804832e-15
AZA vs. DISU-0.4215035269948810.09595277612928250.632994375217858
AZA vs. IL70.2892644044152780.1331371758919360.898662602392564
AZA vs. SAHA-0.7519395701024890.002215269448883510.0356762517868269
DISU vs. CD32.482711978220961.21088361559885e-102.93454334751399e-09
DISU vs. IL70.7015176916980810.005623134553457090.0807321460889196
DISU vs. SAHA-0.3287437265316210.2604859754871610.637923974092787
DMSO vs. AZA-0.1060219605446750.5267481514937971
DMSO vs. CD32.797345832459914.44089209850063e-161.54508174281552e-14
DMSO vs. DISU0.3133800432081170.1991814314379280.715192797657748
DMSO vs. IL70.4028703247010430.02525511642168910.323235426633221
DMSO vs. SAHA-0.6517647519087210.005933685069826830.0629321377110205
HIV vs. Mock in Activation0.1087625277058170.8619624084507290.999983755607037
HIV vs. Mock in Latency-0.4823224824035210.1598410992731340.999834320637052
IL7 vs. CD33.2117762288626400
SAHA vs. CD32.139322828183187.14349934760605e-099.7688325924159e-08
SAHA vs. IL7-1.044532061608752.16458153171617e-050.000575465643899286
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.834876 0.000305467
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
unknown unknown unknown unknown unknown
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
206980_s_at 1.53 No downregulated in CD8+ cells
210607_at 1.57 No downregulated in CD8+ cells

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
1ETE X-ray 2.2Å A/B/C/D=27-160.
3QS7 X-ray 4.3Å A/B/C/D=27-160.
3QS9 X-ray 7.8Å A/B/C/D=27-160.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa04060 Cytokine-cytokine receptor interaction - Homo sapiens (human)
hsa04640 Hematopoietic cell lineage - Homo sapiens (human)
hsa05200 Pathways in cancer - Homo sapiens (human)